Arcadia Biosciences Annual Income Statement (NASDAQ:RKDA)

Add to My Stocks
$1.71 $0.05 (2.84%) RKDA stock closing price Oct 20, 2016 (Closing)

RKDA stock valuation based on fundamental analysis involves checking and analyzing financial statements and not just the Arcadia Biosciences stock price. In the income statement, an investor can check for important parameters like the topline, the bottomline, the EPS basic, dividends etc. When compared with the corresponding income statement from the past, the latest income statement shows how revenue has decreased from $6.98M to $5.41M and how operating and non operating activities have impacted the RKDA stock. 2015 revenue is $5.41M and has decreased from $6.98M year on year as is evident when you compare the latest figures in the latest Arcadia Biosciences profit and loss statement with those of the prior corresponding period. (See also:Arcadia Biosciences assets and Arcadia Biosciences free cash flow) Arcadia Biosciences revenue for 2015 is $5.41M. View revenue and profit details for latest and last 10 financial years.

show more
Get Income statement for another ticker
Fiscal year is Jan - Dec. 2015 2014 2013
Arcadia Biosciences Net Sales or Revenues
Cost Of Goods Sold (COGS)0.89M1.99M0.67M
Arcadia Biosciences Gross Profit
Research & Development Expense8.96M10.01M8.4M
Selling General & Admin Expense11.11M10.12M7.96M
Income Before Depreciation Depletion Amortization-15.56M-15.15M-10.56M
Depreciation Depletion Amortization---
Non Operating Income0.29M-0.59M0.01M
Interest Expense2.65M1.39M0.62M
Arcadia Biosciences Pretax Income
Provision for Income Taxes0.02M0.26M0.16M
Minority Interest---
Investment Gains Losses--0.93M-1.84M
Other Income---
Income Before Extraordinaries & Disc Operations-17.95M-18.33M-13.19M
Extraordinary Items & Discontinued Operations---
Arcadia Biosciences Net Income (Profit/Loss)
Average Shares used to compute Diluted EPS28.56M2.06M-
Average Shares used to compute Basic EPS28.56M2.06M-
Income Before Nonrecurring Items-17.73M-18.34M-
Income from Nonrecurring Items-0.23M--
Arcadia Biosciences Earnings Per Share Basic Net
Arcadia Biosciences Earnings Per Share Diluted Net
EPS Diluted Before Nonrecurring Items-0.72-10.71-
Preferred Dividends Acc Pd---
Dividends Common---
Dividend Per Share Common---
All figures in USD. M: Millions of USD, B: Billions of USD.

It is very helpful to read a report on Arcadia Biosciences stock analysis. An investor must check the following items in an income statement:
  • Revenue: The money received by selling of goods or services comes under this line item. A YoY growth (See: Arcadia Biosciences revenue chart) implies that the company is growing, which has not been the case with Arcadia Biosciences. One must stay away from stocks whose revenues are declining.
  • Bottom line: Most businesses like Arcadia Biosciences try to improve their bottom line by growing their topline and by increasing their operating efficiency. A healthy bottom line growth implies a good investment.
The income statement is also called the profit and loss statement. Apart from the income statement, one can check the Arcadia Biosciences historical stock prices to check how the price has moved with time. .

Arcadia Biosciences Income Statement - Key Financial Ratios

PS ratio (
price sales ratio
Operating margin
Net profit margin
Dividend yield